TP53 and prostate neoplasm: Since Pten/Trp53 double null mice died of enlarged prostate tumors by 5–6 months of age, we then assessed the sustained impact of Skp2 deficiency on prostate tumorigenesis of Pten/Trp53 mutant mice.